Assessment of Needs Despite 4 decades of efforts and substantial progress in preventing, treating, and managing HIV/AIDS, a safe and effective HIV vaccine continues to be elusive. The development of an HIV vaccine would have a major impact on the spread of this disease and help change the course of the HIV pandemic. With the rapid advancements in developing effective COVID-19 vaccines, it is…
Statement released: February 27, 2024 These recommendations of the U.S. Department of Health and Human Services (HHS) Panel for the Use of Antiretroviral Agents in…
Statement released: February 27, 2024 These recommendations of the U.S. Department of Health and Human Services (HHS) Panel for the Use of Antiretroviral Agents in…
Statement released: February 27, 2024 These recommendations of the U.S. Department of Health and Human Services (HHS) Panel for the Use of Antiretroviral Agents in…
Statement released: February 27, 2024 These recommendations of the U.S. Department of Health and Human Services (HHS) Panel for the Use of Antiretroviral Agents in…
An emergency department opt-out testing programme for bloodborne viruses has helped to diagnose thousands of people with serious infections.
An emergency department opt-out testing programme for bloodborne viruses has helped to diagnose thousands of people with serious infections.
Pfizer on Wednesday said it will set the U.S. price for its COVID-19 antiviral treatment Paxlovid at nearly $1,400 per five-day course when it moves…
Pfizer on Wednesday said it will set the U.S. price for its COVID-19 antiviral treatment Paxlovid at nearly $1,400 per five-day course when it moves…
Pfizer on Wednesday said it will set the U.S. price for its COVID-19 antiviral treatment Paxlovid at nearly $1,400 per five-day course when it moves…
